The revised target implies 260% upside from current levels, driven by multi-year revenue visibility and space sector growth.
Morgan Stanley raised its bull-case price target for Rocket Lab (RKLB) to $293, representing 260% potential upside from the current $81.45 share price. The firm cited the $8 billion Iridium deal and a $2.20 billion backlog as key drivers for long-term revenue visibility in the high-growth space sector.
RKLB has faced volatility, down 17.94% over the past week and 46% below its 52-week high of $151. Despite the pullback, the stock remains up 19.57% year-to-date and 620.92% over five years. Street consensus sits at $114.10, making Morgan Stanley’s target 157% above the average.
Hitting $293 by year-end 2026 hinges on Neutron’s on-time debut, Iridium deal closure by mid-2027, and converting the $151 billion Golden Dome opportunity into contracts. The stock’s recent decline aligns with broader space sector sell-offs following SpaceX’s anticipated 2026 IPO.